Blackhall F - Search Results

1

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.

Patton S, Normanno N, Blackhall F, Murray S, Kerr KM, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R, Thunnissen E. Patton S, et al. Among authors: blackhall f. Br J Cancer. 2014 Jul 15;111(2):413-20. doi: 10.1038/bjc.2014.353. Epub 2014 Jul 1. Br J Cancer. 2014. PMID: 24983368 Free PMC article.

2

Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.

Blackhall FH, Shepherd FA. Blackhall FH, et al. Hematol Oncol Clin North Am. 2004 Oct;18(5):1121-41, ix. doi: 10.1016/j.hoc.2004.06.005. Hematol Oncol Clin North Am. 2004. PMID: 15474338 Review.

3

Erlotinib in non-small cell lung cancer: a review.

Blackhall FH, Rehman S, Thatcher N. Blackhall FH, et al. Expert Opin Pharmacother. 2005 Jun;6(6):995-1002. doi: 10.1517/14656566.6.6.995. Expert Opin Pharmacother. 2005. PMID: 15952927 Review.

4

Where next for gefitinib in patients with lung cancer?

Blackhall F, Ranson M, Thatcher N. Blackhall F, et al. Lancet Oncol. 2006 Jun;7(6):499-507. doi: 10.1016/S1470-2045(06)70725-2. Lancet Oncol. 2006. PMID: 16750500 Review.

5

Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.

Baka S, Manegold C, Buchholz E, Schott-von-Römer K, Lorigan P, Nagel S, Blackhall F, Aschroft L, Thatcher N. Baka S, et al. Among authors: blackhall f. Lung Cancer. 2006 Aug;53(2):165-70. doi: 10.1016/j.lungcan.2006.04.010. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16787686

6

K-ras mutations in non-small-cell lung carcinoma: a review.

Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS. Aviel-Ronen S, et al. Clin Lung Cancer. 2006 Jul;8(1):30-8. doi: 10.3816/CLC.2006.n.030. Clin Lung Cancer. 2006. PMID: 16870043 Review.

7

Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.

Dean EJ, Ranson M, Blackhall F, Holt SV, Dive C. Dean EJ, et al. Among authors: blackhall f. Cancer Treat Rev. 2007 Apr;33(2):203-12. doi: 10.1016/j.ctrv.2006.11.002. Epub 2007 Jan 8. Cancer Treat Rev. 2007. PMID: 17210228 Review.

8

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.

Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C. Bayman NA, et al. Among authors: blackhall f. Clin Lung Cancer. 2008 Mar;9(2):92-101. doi: 10.3816/CLC.2008.n.014. Clin Lung Cancer. 2008. PMID: 18501095 Review.

9

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.

Baka S, Califano R, Ferraldeschi R, Aschroft L, Thatcher N, Taylor P, Faivre-Finn C, Blackhall F, Lorigan P. Baka S, et al. Among authors: blackhall f. Br J Cancer. 2008 Aug 5;99(3):442-7. doi: 10.1038/sj.bjc.6604480. Br J Cancer. 2008. PMID: 18665190 Free PMC article. Clinical Trial.

10

Radiotherapy for small-cell lung cancer-Where are we heading?

Bayman NA, Sheikh H, Kularatne B, Lorigan P, Blackhall F, Thatcher N, Faivre-Finn C. Bayman NA, et al. Among authors: blackhall f. Lung Cancer. 2009 Mar;63(3):307-14. doi: 10.1016/j.lungcan.2008.06.013. Epub 2008 Aug 3. Lung Cancer. 2009. PMID: 18676057 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters